• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      CRISPR Combined with Glowing Proteins for Viral Detection

      CRISPR Combined with Glowing Proteins for Viral Detection

      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

    • Radiology
      Imaging Technique Reveals Contraction Patterns During Labor

      Imaging Technique Reveals Contraction Patterns During Labor

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

    • Cardiology
      Scientists Grow Electrodes Inside The Body

      Scientists Grow Electrodes Inside The Body

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

    • Surgery
      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Self-Assembling Peptides as a Bioink

      Self-Assembling Peptides as a Bioink

      3D Bioengineered Skin Grafts Fit Complex Anatomy

      3D Bioengineered Skin Grafts Fit Complex Anatomy

    • Nanomedicine
      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

A Pill to Replace Needles: Interview with Mir Imran, Chairman and CEO of Rani Therapeutics

July 5th, 2017 Conn Hastings Exclusive, Medicine, Oncology, Pediatrics

Operating within InCube Labs, a multi-disciplinary life sciences R&D lab based in Silicon Valley, Rani Therapeutics is developing a novel approach for the oral delivery of large-molecule drugs such as basal insulin, which is currently delivered via injections. By replacing painful injections with a painless, easy-to-take pill, the technology has the potential to drastically improve the lives of millions of patients suffering from diabetes, osteoporosis, rheumatoid arthritis, multiple sclerosis, and many other chronic conditions.

The idea is that the pill allows biological drugs, such as proteins, that would otherwise be destroyed in the stomach and intestine, to be delivered orally. This means that patients don’t have to undergo painful injections. For diabetic patients, who must inject insulin daily, this could mean that they don’t need to worry about needles and painful injections. The pill protects the drug inside itself until it reaches the intestine, where needles made of sugar emerge from the pill and inject the drug directly into the wall of the intestine.

Medgadget had the opportunity to ask Mir Imran, Chairman and CEO of Rani Therapeutics, some questions about the technology. Mir Imran is a prolific inventor of medical devices and has founded more than 20 life sciences companies. Mir holds more than 300 issued patents and is perhaps most well-known for his pioneering contributions to the first FDA-approved Automatic Implantable Cardioverter Defibrillator.

See the technology in action here:

 

Conn Hastings, Medgadget: Please introduce yourself and tell us a little about how you got into medical technology in general.

Mir Imran, Rani Therapeutics: My passion is developing and commercializing medical innovations. I have been an entrepreneur for the past 35 years, and my focus has been on solving major unmet clinical needs. I have a background in engineering and medicine, but even from a very young age, I loved to solve problems and understand how things worked. As a child in Hyderabad, India, I often took apart anything I could get my hands on to see how it worked. My mother eventually started buying toys for me in pairs — one to play with, the other to break down. At 8 years old, I made toys of wood, string and glue, and sold them to classmates. As a teenager, I took radio repair classes. I built AM radios, fit them inside matchboxes and sold them to friends. I later left India for the US and attended Rutgers, where I earned a BS in electrical engineering in 1976. By the time I actually had started my formal engineering training, I had probably a dozen years of hands-on experience.

As a college student, I had an experience that would change the course of my life and led me to the work I do today. I had a summer job working at The Matheney School for Cerebral Palsy Children. They needed engineers to develop communication devices for quadriplegic CP children, so I built a machine for one severely afflicted girl. The unit translated her facial expressions using pre-recorded phrases, allowing her to communicate. The experience was incredibly moving, and it inspired me to pursue medicine. After three years of med school, I decided that I did not want to be a doctor and instead wanted to pursue the business of innovation.

 

Medgadget: What inspired you to design the Rani device?

Mir Imran: Understanding and trying to solve big problems in medicine is what motivates me. Sometimes I discover problems through my own experience or from friends, and in other cases, I learn about problems through other sources. In the case of Rani, I heard from a friend in the world of big pharma that pharma companies spent billions of dollars over the past 40 years trying to convert injectable drugs into pills. And despite that kind of investment of time and money, the attempts were largely unsuccessful. This sounded like a juicy problem. If a solution could be developed, it would affect millions of patients and would have a major impact on the pharma market.

Take insulin as an example. As a protein-based drug, it cannot be ingested, only injected. With my engineering and medical background, I thought about it from a different perspective. If the pill could protect the drug until it reaches the intestine, and then inject the biologic into the intestinal wall — which has no sharp pain receptors — we could achieve successful administration without pain or loss of efficacy. While previous attempts to convert injections into pills have relied exclusively on chemistry, Rani has approached this challenge with engineering. That is the breakthrough.

 

Medgadget: Put simply, how does the technology work? What triggers the drug release in the intestine?

Mir Imran: The Rani pill is essentially a mini swallowable auto-injector that delivers the drug directly into the highly vascular intestinal wall, allowing the drug to be absorbed quickly into the bloodstream. Figuring out how to trigger the injection was a challenge. The answer came to me when I reached for an Alka Seltzer after a spicy Indian dinner. The reaction created in my glass gave me the idea to inflate a balloon and inject the needle. So, the patient swallows the pill, and it protects the proteins from breaking down in the digestive tract. When it reaches the intestine, the balloon inflates, prompting needles made of bioabsorbable materials — such as sugar — to be injected in the intestinal wall.

 

Medgadget: Is positioning in the intestine crucial, or can the pill consistently and reliably deliver the same drug payload? Are there any safety issues – could the pill block the intestine?

Mir Imran: The intestine offers an ideal location for optimal drug absorption into the bloodstream, and its lack of pain receptors make the approach painless. After the drug is administered, the sugar needle dissolves and the balloon and any other ingestible materials pass through and exit the body, without risk of blockage.

 

Medgadget: What types of drugs can be delivered using the pills? What diseases could these pills be useful for?

Mir Imran: The pill was designed with biologic drugs in mind, such as basal insulin, adalimumab, Human Interferon, and human growth hormone, each a multi-billion dollar market. Patients might recognize brand names, such as Humira® and Avonex®; these are examples of injectable biologics. We have partnered with two of the largest pharma companies — Novartis and AstraZeneca – to test their molecules on our platform. We are also testing a number of off-patent biologics.

 

Medgadget: Getting people to take drugs consistently is a challenge. Do you think that this pill could substantially enhance patient compliance for diseases where injections are currently needed?

Mir Imran: Certainly. Fear of needles is a major issue for patient compliance, and I saw recent estimates that non-compliance incurs costs $290 billion per year in complications and related hospitalizations.

Hundreds of millions of patients rely on biologic drugs, including people with diabetes, multiple sclerosis, and rheumatoid arthritis. We are talking about patient compliance and outcomes on a massive scale.

Let’s look at a specific example: there’s a basal insulin drug, Sanofi’s Lantus, which has been the historical market leader. About a year ago, Novo Nordisk came out with Tresiba, which was a longer acting insulin. In this case, the drug delivery innovation was a formulation change, causing the insulin to release over 42 hours, which resulted in patients experiencing fewer low blood sugar events between meals. Patients responded very quickly and enthusiastically when drug delivery reduced the frequency of these painful injections. Tresiba is on the way to a billion dollars in revenue within a year of marketing.

Now, imagine eliminating injections all together and delivering the drug through the oral route. This technology could be a game changer for pharma companies that license our technology. Because the market shifts happen very rapidly, partners could end up owning the market very quickly. For patients, this could mean they no longer have to fear or dread the treatment plans designed to help them.

Link: Rani Therapeutics…

Conn Hastings

Conn Hastings received a PhD from the Royal College of Surgeons in Ireland for his work in drug delivery, investigating the potential of injectable hydrogels to deliver cells, drugs and nanoparticles in the treatment of cancer and cardiovascular diseases. After achieving his PhD and completing a year of postdoctoral research, Conn pursued a career in academic publishing, before becoming a full-time science writer and editor, combining his experience within the biomedical sciences with his passion for written communication.

Sponsored
Venture builder BHV Partners launches Conus Airway to improve anaesthesia  and respiratory surgery

Venture builder BHV Partners launches Conus Airway to improve anaesthesia and respiratory surgery

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

interviews & reviews
Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email